Estradiol decreases xanthine dehydrogenase enzyme activity and protein expression in non-tumorigenic and malignant human mammary epithelial cells

Journal of Cellular Biochemistry

Volumn 108, Issue 3, 2009, Pages 688-692

  Taibi, Gennaro ^a   Carruba, Giuseppe ^b   Miceli, Vitale ^b   Cocciadiferro, Letizia ^b   Nicotra, Concetta M A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b ARNAS Civico   (Italy)

Author keywords

Estradiol; Retinoic acid; Xanthine dehydrogenase; Xanthine oxidase

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN; ESTRADIOL; MESSENGER RNA; RETINAL; RETINOIC ACID; RETINOL; XANTHINE DEHYDROGENASE;

ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION;

CELL LINE, TUMOR; EPITHELIAL CELLS; ESTRADIOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; RNA, MESSENGER; TRETINOIN; XANTHINE DEHYDROGENASE;

EID: 70350176495     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22305     Document Type: Article

References (39)

1. Baker ME. 2001. Evolution of 17β-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action.Mol Cell Endocrinol 171:211-215.
2. Bistulfi G, Pozzi S, Ren MQ, Rossetti S, Sacchi N. 2006. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: Implications for predicting breast cancer risk. Cancer Res 66:10308-10314. (Pubitemid 44799749)
3. Boerman MHEM, Napoli JL. 1996. Cellular retinol-binding protein-supported retinoic acid synthesis. Am Soc Biochem Mol Biol 271:5610-5616.
4. Budhiraja R, Kayyali US, Karamsetty M, Fogel M, Hill NS, Chalkley R, Finlay GA, Hassoun PM. 2003. Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism. Antioxid Redox Signal 5:705-711. (Pubitemid 37462053)
5. Fontana JA. 1988. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp Cell Biol 56:136-144.
6. Fontana JA, Burrows Mezu A, Cooper BN, Miranda D. 1990. Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. Cancer Res 50:1997-2002. (Pubitemid 20115065)
7. Hayden LJ, Satre MA. 2002. Alterations in cellular retinol metabolism contribute to differential retinoid responsiveness in normal human mammary epithelial cells versus breast cancer cells. Breast Cancer Res Treat 72:95-105.
8. Hille R, Nishino T. 1995. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J 9:995-1003.
9. Hunt J, Massey V. 1992. Purification and properties of milk xanthine dehydrogenase. J Biol Chem 267:21479-21485.
10. 3 or antiestrogen to inhibit human breast cancer cell proliferation. J Steroid Biochem Mol Biol 39:455-460.
11. Kooij A, Schiller HJ, Schijns M, Van Noorden CJF, Frederiks WM. 1994. Conversion of xanthine dehydrogenase into xanthine oxidase in rat liver and plasma at the onset of reperfusion after ischemia. Hepatology 19:1488-1495. (Pubitemid 24166473)
12. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira-Y-Lopez R. 2000. Cellular retinol-binding protein and breast cancer. J Natl Cancer Inst 92:475-480. (Pubitemid 30182884)
13. Kuppumbatti YS, Rexer B, Nakajo S, Nakaya K, Mira-Y-Lopez R. 2001. CRBP suppresses breast cancer survival and anchorage-independent growth. Oncogene 20:7413-7419. (Pubitemid 33078212)
14. Levin ER. 2002. Cellular functions of plasma membrane estrogens receptors. Steroids 67:471-473.
15. Lidén M, Tryggvason K, Eriksson U. 2005. The C-terminal region of 11-cis-retinol/ androgen dehydrogenase I (CRADI) confers ER localization and in vivo enzymatic function. Exp Cell Res 311:205-217. (Pubitemid 41636314)
16. Linder N, Lundin J, Isola J, Lundin M, Raivio KO, Joensuu H. 2005. Downregulated xanthine oxidoreductase is a feature of aggressive breast cancer. Clin Cancer Res 11:4372-4381. (Pubitemid 40825626)
17. Lotan R. 1980. Effects of vitamin A and its analogues (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605:33-91. (Pubitemid 10110754)
18. Lu M, Mira-Y-Lopez R, Nakajo S, Nakaya K, Jing Y. 2005. Expression of estrogen receptor-α, retinoic acid receptor α and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells. Oncogene 24:4362-4369. (Pubitemid 40961759)
19. Marth CH, Bock G, Daxenbichler G. 1985. Effect of 4- hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J Natl Cancer Inst 75:871-875. (Pubitemid 16233962)
20. Massey V, Schopfer LM, Nishino T, Nishino T. 1989. Differences in protein structure of xanthine dehydrogenase and xanthine oxidase revealed by reconstitution with flavine active site probes. J Biol Chem 264:10567-10573. (Pubitemid 19161624)
21. McManaman JL, Bain DL. 2002. Structural and conformational analysis of the oxidase to dehydrogenase conversion of xanthine oxidoreductase. J Biol Chem 277:21261-21268.
22. Mira-Y-Lopez R, Zheng WL, Kuppumbatti YS, Rexer B, Jing Y, Ong DE. 2000. Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells. J Cell Physiol 185:302-309. (Pubitemid 30740371)
23. Moon RC, Metha RG. 1990. Chemoprevention of mammary cancer by retinoids. Basic Life Sci 52:213-224.
24. Napoli JL. 1996. Retinoic acid biosynthesis and metabolism. FASEB J 10: 993-1001.
25. Niederreither K, Subbarayan V, Dollè P, Chambon P. 1999. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nature Genet 21:444-448.
26. Ottonello S, Scita G, Mantovani G, Cavazzini D, Rossi GL. 1993. Retinol bound to cellular retinol-binding protein is a substrate for cytoplasmic retinoic acid synthesis. J Biol Chem 268:27133-27142. (Pubitemid 24006428)
27. Rexer BN, Zheng WL, Ong DE. 2001. Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF7 cells. Cancer Res 61:7065-7070.
28. Saito T, Nishino T. 1989. Differences in redox and kinetic properties between NAD-dependent and O2-dependent types of rat liver xanthine dehydrogenase. J Biol Chem 264:10015-10022. (Pubitemid 19159271)
29. Saito T, Nishino T, Massey V. 1989. Differences in environment of FAD between NAD-dependent and O2-dependent types of rat liver xanthine dehydrogenase shown by active site probe study. J Biol Chem 264: 15930-15935. (Pubitemid 19238348)
30. Saleem M, Ohshima H. 2004. Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme. Biochem Biophys Res Commun 315:455-462. (Pubitemid 38183128)
31. Segars JH, Marks MS, Hirschfeld S, Driggers PH, Martinez E, Grippo JF, Wahli W, Ozato K. 1993. Inhibition of estrogen-responsive gene activation by retinoid X receptor β: Evidence for multiple inhibitory pathways. Mol Cell Biol 13:2258-2268. (Pubitemid 23097704)
32. Snedecor G, Cochran W, editors. 1967. Statistical methods. Ames, IA: Iowa State University Press. pp. 120-134.
33. Sporn MB, Dunlop NM, Newton DL, Smith JM. 1976. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35:1332-1338.
34. Stirpe F, Della Corte E. 1969. The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem 244:3855-3863.
35. Taibi G, Nicotra CMA. 2007. Xanthine oxidase catalyzes the oxidation of retinol. J Enz Inhib Med Chem 22:471-476. (Pubitemid 47225711)
36. Taibi G, Di Gaudio F, Nicotra CMA. 2008. Xanthine dehydrogenase processes retinol to retinoic acid in human mammary epithelial cells. J Enz Inhib Med Chem 23:317-327. (Pubitemid 351935050)
37. Taibi G, Carruba G, Cocciadiferro L, Granata OM, Nicotra CMA. 2009. Low levels of xanthine dehydrogenase and of cellular retinol binding protein are responsible of the retinoic deficiency in malignant human mammary epithelial cells. In Bradlow L.H. and Carruba G, editors Steroid Enzymes and Cancer. Ann NY Acad Sci 1155:268-272.
38. Waud WR, Rajagopalan KV. 1976. The mechanism of conversion of rat liver xanthinedehydrogenase from an NAD-dependent form (type D) to an O2-dependent type (type O). Arch Biochem Biophys 172:354-364.
39. Zhao D, McCaffery P, Ivins KJ, Neve RL, Hogan P, Chin WH, Drager UC. 2004. Molecular identification of a major retinoic acid synthesizing enzyme, a retina specific dehydrogenase. Eur J Biochem 240:15-22.